Clinical Outcome Measure at Stryker Spine
Launched by STRYKER SPINE · Jan 17, 2024
Trial Information
Current as of July 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effectiveness of certain surgical devices made by Stryker for treating conditions like Degenerative Disc Disease and Degenerative Scoliosis. It involves collecting information from patients who have already had surgery or will have surgery using these devices. The goal is to understand how well these devices work in real-life situations after the surgery.
To participate, you need to be between 65 and 74 years old and meet specific criteria related to the Stryker device being used. If you have questions about whether you qualify, you can reach out to one of the doctors involved in the study or check the instructions for the device. While the trial is not yet recruiting participants, those who join can expect to be part of a comprehensive follow-up that looks at their recovery and outcomes after surgery. It’s a chance to contribute to research that could help improve care for others with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.
- Exclusion Criteria:
- • • The exclusion criteria are based on the contraindications as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.
About Stryker Spine
Stryker Spine, a division of Stryker Corporation, is a leading innovator in spinal implant technology and surgical solutions. Committed to advancing the field of spine care, Stryker Spine focuses on developing cutting-edge products and therapies designed to enhance surgical outcomes and improve patient quality of life. With a robust portfolio that includes spinal implants, instrumentation, and biologics, the company prioritizes clinical research and trials to ensure the safety and efficacy of its offerings. Stryker Spine's dedication to innovation and excellence positions it at the forefront of the spine industry, making significant contributions to the evolution of spinal surgery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported